RNA profiling of MS brain tissues
- PMID: 18782500
RNA profiling of MS brain tissues
Abstract
Recently, the introduction of RNA profiling using microarray technology has helped to elucidate gene expression changes in diseased tissue samples from postmortem human brains. Especially, in the field of multiple sclerosis (MS) research, microarray-based RNA profiling has been applied in the hope to identify disease specific alterations. The lack of good biomarkers for diagnostic as well as for prognostic purposes, but also the need for new drug targets and for a better understanding of the pathophysiology, makes this technique a valuable tool. Different RNA profiling approaches have been used, addressing distinct scientific questions. MS brain tissue samples have been proven to be an appropriate source for RNA profiling to investigate molecular pathomechanisms. This work discusses the critical parameters for RNA profiling of MS brain tissues, and reviews the results obtained by microarray studies analyzing differential gene expression in MS brain tissues.
Similar articles
-
Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.Expert Rev Mol Diagn. 2006 Nov;6(6):843-55. doi: 10.1586/14737159.6.6.843. Expert Rev Mol Diagn. 2006. PMID: 17140371 Review.
-
Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis.Clin Neurol Neurosurg. 2004 Jun;106(3):223-9. doi: 10.1016/j.clineuro.2004.02.019. Clin Neurol Neurosurg. 2004. PMID: 15177772 Review.
-
Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology.J Neurosci Methods. 2007 Sep 30;165(2):198-209. doi: 10.1016/j.jneumeth.2007.06.001. Epub 2007 Jun 7. J Neurosci Methods. 2007. PMID: 17628689
-
Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.J Neuroimmunol. 2004 Jul;152(1-2):154-67. doi: 10.1016/j.jneuroim.2004.03.011. J Neuroimmunol. 2004. PMID: 15223248
-
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.Science. 2001 Nov 23;294(5547):1731-5. doi: 10.1126/science.1062960. Science. 2001. PMID: 11721059
Cited by
-
Age-related changes of gene expression in the neocortex: preliminary data on RNA-Seq of the transcriptome in three functionally distinct cortical areas.Dev Psychopathol. 2012 Nov;24(4):1427-42. doi: 10.1017/S0954579412000818. Dev Psychopathol. 2012. PMID: 23062308 Free PMC article.
-
Gene expression profiling in multiple sclerosis brain.Neurobiol Dis. 2012 Jan;45(1):108-14. doi: 10.1016/j.nbd.2010.12.003. Epub 2010 Dec 13. Neurobiol Dis. 2012. PMID: 21147224 Free PMC article. Review.
-
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.Mult Scler. 2013 Sep;19(10):1249-54. doi: 10.1177/1352458513500554. Mult Scler. 2013. PMID: 23996595 Free PMC article. Review.
-
Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis.J Neuroimmune Pharmacol. 2012 Dec;7(4):914-26. doi: 10.1007/s11481-012-9409-5. Epub 2012 Oct 12. J Neuroimmune Pharmacol. 2012. PMID: 23065460 Free PMC article. Review.
-
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis.Nat Genet. 2010 May;42(5):392-9. doi: 10.1038/ng.557. Epub 2010 Mar 28. Nat Genet. 2010. PMID: 20348957
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical